首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   572篇
  免费   5篇
  国内免费   8篇
系统科学   9篇
丛书文集   1篇
教育与普及   1篇
理论与方法论   9篇
现状及发展   113篇
研究方法   71篇
综合类   351篇
自然研究   30篇
  2021年   3篇
  2020年   2篇
  2019年   5篇
  2018年   3篇
  2017年   5篇
  2016年   4篇
  2015年   6篇
  2014年   6篇
  2013年   12篇
  2012年   47篇
  2011年   76篇
  2010年   13篇
  2009年   6篇
  2008年   36篇
  2007年   38篇
  2006年   46篇
  2005年   43篇
  2004年   34篇
  2003年   24篇
  2002年   27篇
  2001年   8篇
  2000年   12篇
  1999年   3篇
  1998年   2篇
  1996年   3篇
  1995年   6篇
  1994年   5篇
  1991年   2篇
  1990年   5篇
  1989年   7篇
  1987年   9篇
  1986年   4篇
  1985年   6篇
  1984年   6篇
  1983年   2篇
  1982年   2篇
  1979年   5篇
  1978年   2篇
  1977年   3篇
  1975年   4篇
  1974年   5篇
  1973年   7篇
  1972年   7篇
  1971年   4篇
  1970年   3篇
  1968年   2篇
  1966年   9篇
  1965年   5篇
  1956年   1篇
  1945年   1篇
排序方式: 共有585条查询结果,搜索用时 15 毫秒
561.
S M Partridge  D F Elsden  J Thomas  A Dorfman  A Telser  P L Ho 《Nature》1966,209(5021):399-400
  相似文献   
562.
Résumé La mobilisation des acides gras libres (FFA) induite par les hormones lipolytiques dans les cellules adipeuses isolées est inhibée par l'adjonction d'ouabaÏne. Le transport des FFA hors de la cellule semble lié en partie à la pompe Na+-K+. Une hypothèse sur le mode d'action de l'ouabaÏne est discutée.

This work has been supported by the Fonds National Suisse de la Recherche Scientifique, Grant No. 3244, Bern (Switzerland) and by a grant-in-aid from the Fondation Emil Barell pour le Développement des Recherches Médico-Scientifiques, Basel (Switzerland).  相似文献   
563.
564.
565.
566.
Phosphoinositide-3-OH kinases (PI(3)Ks) constitute a family of evolutionarily conserved lipid kinases that regulate a vast array of fundamental cellular responses, including proliferation, transformation, differentiation and protection from apoptosis. PI(3)K-mediated activation of the cell survival kinase PKB/Akt, and negative regulation of PI(3)K signalling by the tumour suppressor PTEN (refs 3, 4) are key regulatory events in tumorigenesis. Thus, a model has arisen that PI(3)Ks promote development of cancers. Here we report that genetic inactivation of the p110gamma catalytic subunit of PI(3)Kgamma (ref. 8) leads to development of invasive colorectal adenocarcinomas in mice. In humans, p110gamma protein expression is lost in primary colorectal adenocarcinomas from patients and in colon cancer cell lines. Overexpression of wild-type or kinase-dead p110gamma in human colon cancer cells with mutations of the tumour suppressors APC and p53, or the oncogenes beta-catenin and Ki-ras, suppressed tumorigenesis. Thus, loss of p110gamma in mice leads to spontaneous, malignant epithelial tumours in the colorectum and p110gamma can block the growth of human colon cancer cells.  相似文献   
567.
Bv8 regulates myeloid-cell-dependent tumour angiogenesis   总被引:1,自引:0,他引:1  
Shojaei F  Wu X  Zhong C  Yu L  Liang XH  Yao J  Blanchard D  Bais C  Peale FV  van Bruggen N  Ho C  Ross J  Tan M  Carano RA  Meng YG  Ferrara N 《Nature》2007,450(7171):825-831
Bone-marrow-derived cells facilitate tumour angiogenesis, but the molecular mechanisms of this facilitation are incompletely understood. We have previously shown that the related EG-VEGF and Bv8 proteins, also known as prokineticin 1 (Prok1) and prokineticin 2 (Prok2), promote both tissue-specific angiogenesis and haematopoietic cell mobilization. Unlike EG-VEGF, Bv8 is expressed in the bone marrow. Here we show that implantation of tumour cells in mice resulted in upregulation of Bv8 in CD11b+Gr1+ myeloid cells. We identified granulocyte colony-stimulating factor as a major positive regulator of Bv8 expression. Anti-Bv8 antibodies reduced CD11b+Gr1+ cell mobilization elicited by granulocyte colony-stimulating factor. Adenoviral delivery of Bv8 into tumours was shown to promote angiogenesis. Anti-Bv8 antibodies inhibited growth of several tumours in mice and suppressed angiogenesis. Anti-Bv8 treatment also reduced CD11b+Gr1+ cells, both in peripheral blood and in tumours. The effects of anti-Bv8 antibodies were additive to those of anti-Vegf antibodies or cytotoxic chemotherapy. Thus, Bv8 modulates mobilization of CD11b+Gr1+ cells from the bone marrow during tumour development and also promotes angiogenesis locally.  相似文献   
568.
Yang J  Goldstein JI  Scott ER 《Nature》2007,446(7138):888-891
In our Solar System, the planets formed by collisional growth from smaller bodies. Planetesimals collided to form Moon-to-Mars-sized protoplanets in the inner Solar System in 0.1-1 Myr, and these collided more energetically to form planets. Insights into the timing and nature of collisions during planetary accretion can be gained from meteorite studies. In particular, iron meteorites offer the best constraints on early stages of planetary accretion because most are remnants of the oldest bodies, which accreted and melted in <1.5 Myr, forming silicate mantles and iron-nickel metallic cores. Cooling rates for various groups of iron meteorites suggest that if the irons cooled isothermally in the cores of differentiated bodies, as conventionally assumed, these bodies were 5-200 km in diameter. This picture is incompatible, however, with the diverse cooling rates observed within certain groups, most notably the IVA group, but the large uncertainties associated with the measurements do not preclude it. Here we report cooling rates for group IVA iron meteorites that range from 100 to 6,000 K Myr(-1), increasing with decreasing bulk Ni. Improvements in the cooling rate model, smaller error bars, and new data from an independent cooling rate indicator show that the conventional interpretation is no longer viable. Our results require that the IVA meteorites cooled in a 300-km-diameter metallic body that lacked an insulating mantle. This body probably formed approximately 4,500 Myr ago in a 'hit-and-run' collision between Moon-to-Mars-sized protoplanets. This demonstrates that protoplanets of approximately 10(3) km size accreted within the first 1.5 Myr, as proposed by theory, and that fragments of these bodies survived as asteroids.  相似文献   
569.
570.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号